Health Catalyst, Inc. – NASDAQ:HCAT
Health Catalyst stock price today
$2.98
-4.1
-57.91%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market open
Closed in about 1 hour
Health Catalyst stock price monthly change
+9.43%
month
Health Catalyst stock price quarterly change
+9.43%
quarter
Health Catalyst stock price yearly change
-26.02%
year
Health Catalyst key metrics
Market Cap | 425.93M |
Enterprise value | 836.29M |
P/E | -4.62 |
EV/Sales | 3.02 |
EV/EBITDA | -9.70 |
Price/Sales | 2.55 |
Price/Book | 1.65 |
PEG ratio | -0.22 |
EPS | -1.85 |
Revenue | 296.79M |
EBITDA | -54.69M |
Income | -105.54M |
Revenue Q/Q | 1.15% |
Revenue Y/Y | 5.23% |
Profit margin | -49.74% |
Oper. margin | -50.68% |
Gross margin | 48.21% |
EBIT margin | -50.68% |
EBITDA margin | -18.43% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeHealth Catalyst stock price history
Health Catalyst stock forecast
Health Catalyst financial statements
| Jun 2023 | 73.21M | -32.61M | -44.55% |
|---|---|---|---|
| Sep 2023 | 73.77M | -22.03M | -29.86% |
| Dec 2023 | 75.08M | -30.31M | -40.37% |
| Mar 2024 | 74.72M | -20.58M | -27.55% |
| Sep 2025 | 87.62M | 8.75M | 9.99% |
|---|---|---|---|
| Oct 2025 | 87.03M | 8.43M | 9.69% |
| Dec 2025 | 89.37M | 8.76M | 9.81% |
| Mar 2026 | 89.92M | 5.53M | 6.16% |
Analysts Price target
Financials & Ratios estimates
| Jun 2023 | 722903000 | 333.03M | 46.07% |
|---|---|---|---|
| Sep 2023 | 712920000 | 330.52M | 46.36% |
| Dec 2023 | 701814000 | 334.89M | 47.72% |
| Mar 2024 | 695112000 | 337.90M | 48.61% |
| Jun 2023 | -11.57M | -7.41M | 1.20M |
|---|---|---|---|
| Sep 2023 | 3.11M | -24.85M | 1.04M |
| Dec 2023 | -19.04M | 29.91M | 395K |
| Mar 2024 | 10.26M | 83.98M | 863K |
Health Catalyst alternative data
| Aug 2023 | 1,200 |
|---|---|
| Sep 2023 | 1,200 |
| Oct 2023 | 1,200 |
| Nov 2023 | 1,200 |
| Dec 2023 | 1,200 |
| Jan 2024 | 1,200 |
| Feb 2024 | 1,200 |
| Mar 2024 | 1,300 |
| Apr 2024 | 1,300 |
| May 2024 | 1,300 |
| Jun 2024 | 1,300 |
| Jul 2024 | 1,300 |
Health Catalyst other data
79.56%
-19.37%
of HCAT is owned by hedge funds
153
-19
42.70M
-9.93M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Jan 2024 | 0 | 3163 |
| Feb 2024 | 26200 | 3262 |
| Mar 2024 | 0 | 2005 |
| Apr 2024 | 0 | 2005 |
| May 2024 | 0 | 14643 |
| Jun 2024 | 0 | 25923 |
| Jul 2024 | 0 | 6498 |
| Aug 2024 | 0 | 6537 |
| Sep 2024 | 0 | 22326 |
| Oct 2024 | 0 | 6533 |
| Nov 2024 | 0 | 6574 |
| Dec 2024 | 0 | 80082 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Sale | GALLAGHER DUNCAN director | Common Stock | 4,500 | $6.98 | $31,415 | ||
Sale | LLEWELYN LINDA officer: Chief Pe.. | Common Stock | 6,442 | $7.89 | $50,795 | ||
Sale | ALGER JASON officer: Chief Financial Officer | Common Stock | 19,599 | $8.32 | $163,044 | ||
Sale | LANDRY BENJAMIN officer: General Counsel | Common Stock | 19,268 | $8.32 | $160,290 | ||
Sale | LESUEUR DANIEL officer: Chief Operating Officer | Common Stock | 22,773 | $7.7 | $175,238 | ||
Sale | FREEMAN KEVIN LEE officer: Chief Commercial Officer | Common Stock | 7,500 | $8.94 | $67,073 | ||
Sale | LLEWELYN LINDA officer: Chief Pe.. | Common Stock | 1,365 | $8.5 | $11,603 | ||
Sale | LESUEUR DANIEL officer: Chief Operating Officer | Common Stock | 5,209 | $7.7 | $40,125 | ||
Sale | LLEWELYN LINDA officer: Chief Pe.. | Common Stock | 1,324 | $8.16 | $10,804 | ||
Sale | LESUEUR DANIEL officer: Chief Operating Officer | Common Stock | 5,209 | $7.68 | $40,010 |
| Patent |
|---|
Application Filling date: 15 Jan 2021 Issue date: 6 May 2021 |
Grant Filling date: 3 Feb 2020 Issue date: 16 Feb 2021 |
Application Filling date: 3 Feb 2020 Issue date: 5 Nov 2020 |
Application Filling date: 1 Nov 2019 Issue date: 4 Jun 2020 |
Grant Filling date: 7 Oct 2016 Issue date: 10 Mar 2020 |
Grant Filling date: 28 Mar 2017 Issue date: 4 Feb 2020 |
Grant Filling date: 28 Mar 2017 Issue date: 5 Nov 2019 |
| Quarter | Transcript |
|---|---|
| Q1 2024 9 May 2024 | Q1 2024 Earnings Call Transcript |
| Q4 2023 22 Feb 2024 | Q4 2023 Earnings Call Transcript |
| Q3 2023 10 Nov 2023 | Q3 2023 Earnings Call Transcript |
| Q2 2023 8 Aug 2023 | Q2 2023 Earnings Call Transcript |
Health Catalyst: Improved Demand Environment Reinforces My Buy Rating
Health Catalyst Sees Growth In Tech-Enabled Managed Services
Health Catalyst: Share Price Still Not Reflective Of Intrinsic Value
Health Catalyst: Riding A Steady Trend
HCA Healthcare: Expect Performance To Meet Long-Term Target Over Time
Health Catalyst: Tailwinds As Hospitals Use Tech To Offset Higher Costs
Health Catalyst: Looking For A Turnaround For This 'Bio Boom' Candidate
Premier: Attractively Valued In An Important Market
The Stocks To Focus On Today
-
What's the price of Health Catalyst stock today?
One share of Health Catalyst stock can currently be purchased for approximately $2.98.
-
When is Health Catalyst's next earnings date?
Unfortunately, Health Catalyst's (HCAT) next earnings date is currently unknown.
-
Does Health Catalyst pay dividends?
No, Health Catalyst does not pay dividends.
-
How much money does Health Catalyst make?
Health Catalyst has a market capitalization of 425.93M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 7.13% to 295.94M US dollars.
-
What is Health Catalyst's stock symbol?
Health Catalyst, Inc. is traded on the NASDAQ under the ticker symbol "HCAT".
-
What is Health Catalyst's primary industry?
Company operates in the Healthcare sector and Medical - Healthcare Information Services industry.
-
How do i buy shares of Health Catalyst?
Shares of Health Catalyst can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Health Catalyst's key executives?
Health Catalyst's management team includes the following people:
- Mr. Daniel D. Burton Chief Executive Officer & Director(age: 50, pay: $368,280)
- Mr. Paul Horstmeier Chief Operating Officer(age: 64, pay: $357,500)
- Mr. Daniel H. Orenstein Gen. Counsel & Sec.(age: 55, pay: $345,640)
- Ms. Linda Llewelyn Chief People Officer(age: 58, pay: $287,850)
-
How many employees does Health Catalyst have?
As Jul 2024, Health Catalyst employs 1,300 workers.
-
When Health Catalyst went public?
Health Catalyst, Inc. is publicly traded company for more then 6 years since IPO on 25 Jul 2019.
-
What is Health Catalyst's official website?
The official website for Health Catalyst is healthcatalyst.com.
-
Where are Health Catalyst's headquarters?
Health Catalyst is headquartered at 10897 South River Front Parkway, South Jordan, UT.
-
How can i contact Health Catalyst?
Health Catalyst's mailing address is 10897 South River Front Parkway, South Jordan, UT and company can be reached via phone at 801 708 6800.
Health Catalyst company profile:
Health Catalyst, Inc.
healthcatalyst.comExchange:
NASDAQ
Full time employees:
1,300
Industry:
Medical - Healthcare Information Services
Sector:
Healthcare
Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its offerings include data and analytics platform, a commercial-grade data and analytics platform for the healthcare sector; AI and data science, providing integration of AI into existing business intelligence tools, increasing analytics accuracy; population health management identifies improvement across the care continuum as well as actionable guidance for success and automated workflows; financial transformation providing costing and labor productivity insights and revenue capture; quality and safety improvement using clinical quality and patient safety data, analytics, and expert services; and national data ecosystem for thought leadership and mutual knowledge exchange to transform care delivery through next-gen insights. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is based in South Jordan, Utah.
10897 South River Front Parkway
South Jordan, UT 84095
South Jordan, UT 84095
CIK: 0001636422
ISIN: US42225T1079
CUSIP: 42225T107
